These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 21959887)
1. Radioembolization of hepatic tumors: flow redistribution after the occlusion of intrahepatic arteries. Lauenstein TC; Heusner TA; Hamami M; Ertle J; Schlaak JF; Gerken G; Bockisch A; Antoch G Rofo; 2011 Nov; 183(11):1058-64. PubMed ID: 21959887 [TBL] [Abstract][Full Text] [Related]
2. Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization. Heusner TA; Hamami ME; Ertle J; Hahn S; Poeppel T; Hilgard P; Bockisch A; Forsting M; Antoch G Rofo; 2010 Jul; 182(7):603-8. PubMed ID: 20183775 [TBL] [Abstract][Full Text] [Related]
3. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe. Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039 [TBL] [Abstract][Full Text] [Related]
4. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma. Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors. Bilbao JI; Garrastachu P; Herráiz MJ; Rodríguez M; Iñarrairaegui M; Rodríguez J; Hernández C; de la Cuesta AM; Arbizu J; Sangro B Cardiovasc Intervent Radiol; 2010 Jun; 33(3):523-31. PubMed ID: 19841973 [TBL] [Abstract][Full Text] [Related]
6. Computed tomography hepatic arteriography has a hepatic falciform artery detection rate that is much higher than that of digital subtraction angiography and 99mTc-MAA SPECT/CT: implications for planning 90Y radioembolization? Burgmans MC; Too CW; Kao YH; Goh AS; Chow PK; Tan BS; Tay KH; Lo RH Eur J Radiol; 2012 Dec; 81(12):3979-84. PubMed ID: 22954411 [TBL] [Abstract][Full Text] [Related]
7. Outpatient single-session yttrium-90 glass microsphere radioembolization. Gates VL; Marshall KG; Salzig K; Williams M; Lewandowski RJ; Salem R J Vasc Interv Radiol; 2014 Feb; 25(2):266-70. PubMed ID: 24332243 [TBL] [Abstract][Full Text] [Related]
8. Hepatic Flow Redistribution is Feasible in Patients with Hepatic Malignancies Undergoing Same-Day Work-Up Angiography and Yttrium-90 Microsphere Radioembolization. Ezponda A; Rodríguez-Fraile M; Morales M; Vivas I; De La Torre M; Sangro B; Bilbao JI Cardiovasc Intervent Radiol; 2020 Jul; 43(7):987-995. PubMed ID: 31848672 [TBL] [Abstract][Full Text] [Related]
9. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma]. Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369 [TBL] [Abstract][Full Text] [Related]
10. Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts? Theysohn JM; Ruhlmann M; Müller S; Dechene A; Best J; Haubold J; Umutlu L; Gerken G; Bockisch A; Lauenstein TC PLoS One; 2015; 10(9):e0137587. PubMed ID: 26335790 [TBL] [Abstract][Full Text] [Related]
11. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study. Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133 [TBL] [Abstract][Full Text] [Related]
12. Embolization of parasitized extrahepatic arteries to reestablish intrahepatic arterial supply to tumors before yttrium-90 radioembolization. Abdelmaksoud MH; Louie JD; Kothary N; Hwang GL; Kuo WT; Hofmann LV; Hovsepian DM; Sze DY J Vasc Interv Radiol; 2011 Oct; 22(10):1355-62. PubMed ID: 21961979 [TBL] [Abstract][Full Text] [Related]
13. Consolidation of hepatic arterial inflow by embolization of variant hepatic arteries in preparation for yttrium-90 radioembolization. Abdelmaksoud MH; Louie JD; Kothary N; Hwang GL; Kuo WT; Hofmann LV; Hovsepian DM; Sze DY J Vasc Interv Radiol; 2011 Oct; 22(10):1364-1371.e1. PubMed ID: 21961981 [TBL] [Abstract][Full Text] [Related]
14. Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors. Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Todica A; Bartenstein P; Hacker M; Haug AR J Nucl Med; 2015 Nov; 56(11):1654-60. PubMed ID: 26315830 [TBL] [Abstract][Full Text] [Related]
15. Measurement of the Tumor-to-Normal Ratio for Radioembolization of Hepatocellular Carcinoma: A Prospective Study Comparing 2-Dimensional Perfusion Angiography, Technetium-99m Macroaggregated Albumin, and Yttrium-90 SPECT/CT. Brunson CP; McGregor HJ; Hennemeyer CT; Patel MV; Woodhead GJ; Young SJ J Vasc Interv Radiol; 2024 Jan; 35(1):94-101. PubMed ID: 37783268 [TBL] [Abstract][Full Text] [Related]
16. Systematic evaluation of tumoral 99mTc-MAA uptake using SPECT and SPECT/CT in 502 patients before 90Y radioembolization. Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Bartenstein P; Hacker M; Haug AR J Nucl Med; 2015 Mar; 56(3):333-8. PubMed ID: 25655623 [TBL] [Abstract][Full Text] [Related]
17. Development of new hepaticoenteric collateral pathways after hepatic arterial skeletonization in preparation for yttrium-90 radioembolization. Abdelmaksoud MH; Hwang GL; Louie JD; Kothary N; Hofmann LV; Kuo WT; Hovsepian DM; Sze DY J Vasc Interv Radiol; 2010 Sep; 21(9):1385-95. PubMed ID: 20688531 [TBL] [Abstract][Full Text] [Related]
18. Correlation of C-arm CT acquired parenchymal blood volume (PBV) with 99mTc-macroaggregated albumin (MAA) SPECT/CT for radioembolization work-up. Weissinger M; Vogel J; Kupferschläger J; Dittmann H; Castaneda Vega SG; Grosse U; Artzner C; Nikolaou K; la Fougere C; Grözinger G PLoS One; 2020; 15(12):e0244235. PubMed ID: 33378338 [TBL] [Abstract][Full Text] [Related]
19. Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases. Kousik V; Promila P; Verma R; Gupta A Indian J Gastroenterol; 2016 May; 35(3):179-85. PubMed ID: 27185180 [TBL] [Abstract][Full Text] [Related]
20. Identifying aberrant hepatic arteries prior to intra-arterial radioembolization. van den Hoven AF; Smits ML; de Keizer B; van Leeuwen MS; van den Bosch MA; Lam MG Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1482-93. PubMed ID: 24469409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]